Overview
AI/ML-enabled multiomics blood tests for colorectal, lung, and broader multi-cancer early detection, including SimpleScreen CRC and pipeline programs built on real-world training data.
Product and company
Freenome — Biotechnology is a verified product offering linked to the Brel Digital company profile for Freenome.
Use cases
AI/ML-enabled multiomics blood tests for colorectal, lung, and broader multi-cancer early detection, including SimpleScreen CRC and pipeline programs built on real-world training data.
Target customer
Primary care systems, payers, employers, and pharmaceutical partners seeking accessible blood-based cancer screening workflows.
Technologies
Primary technologies assigned from the linked company profile: Deep Learning, Healthcare Analytics, Machine Learning, Medical Imaging, Predictive Analytics.
Sources and references
- Official product / company source: https://www.freenome.com/newsroom/freenome-names-aaron-elliott-as-chief-executive-officer/
- Supporting source: https://www.freenome.com/our-company/chief-executive-officer/
Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.
Last reviewed
This product profile was last reviewed on 2026-07-14.
Correction request
If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.
Features and capabilities
- AI/ML-enabled multiomics blood tests for colorectal, lung, and broader multi-cancer early detection, including SimpleScre
- SimpleScreen CRC
- pipeline programs built on real-world training data
Extracted from the linked company product description already verified on Brel. No capabilities were invented.